Document:

Exhibit 10(j)

 

[TENET LETTERHEAD]

 

June 21, 2013

 

Mr. Keith B. Pitts

Vice Chairman

Vanguard Health Systems, Inc.

 

Dear Keith:

 

I am pleased to offer you supplemental compensation and benefits in consideration of your transition to Tenet Healthcare Corporation in connection with Tenet’s acquisition of Vanguard Health Systems, Inc. (“Acquisition”).  By accepting these terms, you agree to waive any occurrence of “good reason” under your employment agreement with Vanguard that results from Vanguard no longer being a publicly-traded company as a result of the Acquisition or your acceptance of your role described herein.  Except as modified below, other terms of your employment agreement will remain in effect.  The terms included in this letter are contingent on the successful closing of the Acquisition and become effective at that time.

 

1.              Role:  Vice Chairman of Tenet, reporting to Tenet’s President and Chief Executive Officer.  Your position will be located at Tenet’s headquarters in Dallas after a reasonable transition period from Nashville to be mutually agreed upon.  (See Addendum for additional detail.)

 

2.              Compensation and Benefits:  You will be entitled to compensation and benefits as follows:

 

a.              Base Compensation:  Your base compensation will continue to be an annual exempt rate of $700,000.00, payable bi-weekly.

 

b.              Benefits:  You are eligible to receive all standard employee benefits in accordance with Tenet plans.

 

c.               Annual Incentive Plan:  Your position is eligible to participate in Tenet’s Annual Incentive Plan (AIP) according to the terms of the Plan.  Your target award will continue to be 100% of your base salary.  Participating in the AIP does not guarantee that an award will be made.

 

d.              Manager’s Paid Time Off Plan:  You are eligible to participate in the company’s paid time off plan (the “MTO Plan”) according to your tenure with the company (4 weeks per year).

 

e.               Long Term Incentives.  As Vice Chairman, you will be eligible for future long-term incentive grants, which are typically awarded annually and based on guidelines established by Tenet’s Compensation Committee.  In your role, the current guideline for such an award has an annual value of between $2,000,000 and $2,500,000.  In addition, you will receive an up-front grant of restricted stock units (“RSUs”) valued at $2,500,000, which will be granted upon closing of the Acquisition. The RSUs will vest in the same manner as standard annual Tenet RSU grants, over three years in one-third annual increments.

 

3.              Relocation:  Tenet will provide relocation benefits related to your move to Dallas in accordance with its relocation policies for key executives.  The details of these benefits will be provided in a separate communication.

 

 

4.              Supplemental Executive Retirement Plan:  You will be eligible to participate in Tenet’s supplemental executive retirement plan (SERP), which provides enhanced retirement, disability and life insurance benefits, effective as of the close of the Acquisition.  Upon completion of five years of service with Tenet following the closing of the Acquisition, the SERP will credit your pre-closing service with Vanguard for purposes of calculating SERP benefits.  Details of that plan (e.g., benefit accrual levels, vesting terms) will be provided in a separate communication.  Should Tenet’s Compensation Committee determine to freeze or terminate the SERP plan following the Acquisition, you will be provided with a substitute of similar value.

 

5.              Executive Severance Plan:  At the time specified in the next paragraph, you will be eligible to participate in the Executive Severance Plan, which provides you with certain severance benefits in the event of a Qualifying Termination (i.e., Not for Cause or Good Reason) as defined in the plan.  These benefits include severance benefits of two and one-half years of base salary and target annual bonus for a Qualifying Termination, and three years base salary and target annual bonus for Qualifying Termination related to a Change of Control.

 

Participation will require execution of a Tenet Executive Severance Plan Agreement.  Upon execution of this agreement, which must be completed within one year of the closing of the Acquisition, both parties agree to terminate your existing employment agreement with Vanguard.

 

You will receive a separate communication containing more details about the plan, your participation in the plan and an agreement which you will need to sign, from the Executive Compensation Department following your employment date with Tenet.

 

6.              Use of Company Aircraft:  You will have priority access to private aircraft for business travel in accordance with Tenet’s policies.

 

All payments to you are subject to applicable tax withholding, and nothing in this letter constitutes a contract to employ you for any specified time.  This letter may be modified only by a writing signed by both you and a designated senior officer of Tenet.

 

If you accept these supplemental items and benefits, please sign and date this letter and return it to me.  We are very excited about the Acquisition and look forward to you joining our team.

 

	
Sincerely,
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Trevor Fetter
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Trevor   Fetter
    	
 
    	
 
    
	
President   and CEO
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
cc:                                Cathy Fraser,   SVP Human Resources
    	
 
    	
 
    
	
Paul   Slavin, VP Executive and Corporate HR Services
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Acknowledged   and accepted:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Keith B. Pitts
    	
 
    	
Date:
    	
 6/24, 2013
    
	
Signature
    	
 
    	
 
    	
 
    

 

2

 

Addendum

 

Responsibilities of Vice-Chairman:

 

A.            Primary responsibilities:

 

1.              Responsible for sourcing, evaluating, and executing material mergers, acquisitions, divestitures, investments, joint ventures and similar corporate development activities across Tenet’s business lines

 

2.              Management responsibility for Tenet’s current acquisitions and development department

 

3.              Member of Tenet’s Senior Operating Committee (top corporate officers)

 

4.              Advisor on strategies to Tenet’s CEO

 

5.              Member of the board of managers (equivalent to board of directors) of Conifer

 

6.              Represent Tenet as a director of the Federation of American Hospitals and other national-level industry or business organizations

 

7.              Participate in all Tenet board meetings

 

8.              Co-Chair of Tenet’s Capital Expenditure Review Committee (“CERC”)(1)

 

B.            Extensive involvement in the following areas, in coordination with functional leaders:

 

1.              Investor relations (i.e., represent Tenet at selected investor conferences or road shows, in coordination with CFO and SVP of IR)

 

2.              Government relations (in coordination with SVP Public Affairs)

 

3.              Industry relations (i.e., represent Tenet at industry conferences, C-level industry meetings, or other venues, in coordination with SVP Public Affairs)

 

(1)  This management committee approves key investments/expenditures greater than $5 million.

 

3Exhibit 10.1

 

AUXILIUM PHARMACEUTICALS, INC.

2004 EQUITY COMPENSATION PLAN

 

RESTRICTED STOCK UNIT GRANT AGREEMENT

PERFORMANCE SHARE AWARD

 

Auxilium Pharmaceuticals, Inc. (the “Company”) has granted you restricted stock units under the Auxilium Pharmaceuticals, Inc. 2004 Equity Compensation Plan, as amended and restated (the “Plan”).  The terms of the grant are set forth in this Summary of Grant, the Restricted Stock Unit Grant Agreement (the “Agreement”) attached hereto and the Plan.  You should read this Summary of Grant, the Agreement, and the Plan, to fully understand the grant.

 

SUMMARY OF GRANT

 

	
Grantee:
    	
 
    	
[insert   name]
    
	
 
    	
 
    	
 
    
	
Date   of Grant:
    	
 
    	
February [    ],   2014
    
	
 
    	
 
    	
 
    
	
Target   Number of Shares Subject to Grant:
    	
 
    	
This   grant represents the right to receive a target of   [          ] shares of   Company Stock (as defined in the Plan) upon achievement of the Performance   Goals (as defined below) (the “Target Award”).
    
	
 
    	
 
    	
 
    
	
Performance   Period:
    	
 
    	
January 1,   2014 to December 31, 2016, unless otherwise vested and earned earlier   pursuant to a Change of Control (as defined in the Plan) (the “Performance   Period”).
    
	
 
    	
 
    	
 
    
	
Performance   Goals:
    	
 
    	
The   Performance Goals are based on the performance measure set forth on Schedule   A.
    
	
 
    	
 
    	
 
    
	
Vesting   Schedule:
    	
 
    	
Except   as set forth herein, shares of Company Stock will become earned based on the   performance level achieved with respect to the Performance Goals and the   Grantee continuing to be employed by, or provide service to, the Employer   through the last day of the Performance Period, unless otherwise vested and   earned earlier pursuant to a Change of Control (the “Vesting Date”).
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
The   actual number of shares of Company Stock earned may be greater or less than   the Target Award, or even zero, and will be based on the actual performance   level achieved by the Company with respect to the Performance Goals set forth   on Schedule A. Performance level is measured based on the threshold,   target and stretch performance levels set forth on Schedule A. If   actual performance is between performance levels, the number of shares of   Company
    

 

 

	
 
    	
 
    	
Stock   earned will be interpolated on a straight line basis for each 1% above or   below target level performance, rounded down to the nearest whole number;   provided that failure to achieve the threshold performance level with respect   to the Performance Goals will result in no shares of Company Stock being   earned.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Except   as otherwise provided in a written agreement by and between the Grantee and   the Company, if the Grantee ceases to be employed by, or provide service to,   the Employer for any reason prior to the Vesting Date, the Grantee shall   forfeit all rights to receive shares of Company Stock earned upon achievement   of the Performance Goals.
    
	
 
    	
 
    	
 
    
	
Change   of Control:
    	
 
    	
In   the event a Change of Control occurs while the Grantee is employed by, or   providing service to, the Employer, the Performance Period will be considered   completed and will therefore end on the date of the Change of Control and the   shares of Company Stock will become fully vested and earned based on the   greater of (i) the Company’s actual performance level achieved with   respect to the Performance Goals as of the Change of Control date, or (ii) the   target performance level as to the Performance Goals, such that 100% of the   Target Award is earned as of the date of the Change of Control.  For purposes of the foregoing calculation   of actual performance in (i) above, 3-Year Relative Total Shareholder   Return will be calculated using the 20-trading day average closing price   preceding the announcement of the transaction constituting the Change of   Control; provided, that, any issuance of shares of Company Stock that may   become earned based on a Change of Control are contingent upon the   consummation of the Change of Control.
    
	
 
    	
 
    	
 
    
	
Issuance   Schedule:
    	
 
    	
One   share of Company Stock shall be issued to the Grantee for each share of   Company Stock that the Grantee earns upon achievement of the Performance   Goals, if any, within sixty (60) days following the Vesting Date (the   “Payment Date”); provided, however, that such issuance will be made not later   than March 15 of the fiscal year following the end of the Performance   Period.  If the foregoing Vesting   Schedule would result in the Grantee vesting in the right to receive a   fractional share of Company Stock, the number of shares in which the Grantee   becomes vested in the right to receive shall be rounded down to the nearest   whole share of Company Stock.
    

 

2

 

Grantee Acceptance:

 

By signing the acknowledgement below, the Grantee agrees to be bound by the terms and conditions of the Plan, the Agreement and this Summary of Grant and accepts the right to receive shares of Company Stock following the date of the Company’s certification to the Grantee of the award of the shares of Company Stock on the Payment Date in accordance with the terms of this Summary of Grant, the Agreement and the Plan.  The Grantee will accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan, this Summary of Grant or the Agreement.

 

The Grantee acknowledges that the Plan and the Plan prospectus are available on our intranet under “Human Resources” at http://auxlink.auxilium.com/portal/page/portal/Login; provided that paper copies of the Plan and the Plan prospectus are available upon request by contacting the Human Resources Department at jlarmstrong@auxilium.com or 1-484-321-2172.

 

	
 
    	
Agreed and accepted:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Grantee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Date
    

 

3

 

SCHEDULE A

 

Performance Goals

 

The actual number of shares of Company Stock earned will be determined based on the actual performance level achieved with respect to the following performance measure during the Performance Period:

 

Performance Period(1)

 

	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Shares of
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Company Stock
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Earned as a
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Percentage of the
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Target Award
    	
 
    
	
Performance
    	
 
    	
 
    	
 
    	
Performance
    	
 
    	
 
    	
 
    	
(% of Target
    	
 
    
	
Measure
    	
 
    	
Weight
    	
 
    	
Level
    	
 
    	
Performance Goals
    	
 
    	
Award)
    	
 
    
	
3-Year Relative   Total
   Shareholder Return (TSR)
    	
 
    	
100%
    	
 
    	
Threshold
    	
 
    	
Company TSR that   is 50% below Target TSR 
    	
 
    	
50%
    	
 
    
	
 
    	
Target
    	
 
    	
Company TSR equal   to the 75th percentile of the S&P Index (“Target TSR”) 
    	
 
    	
100%
    	
 
    
	
 
    	
 
    	
Stretch
    	
 
    	
Company TSR that   is 50% above Target TSR 
    	
 
    	
150%
    	
 
    

 

(1) The actual number of shares of Company Stock earned will be based on the actual performance level achieved, and vesting will be interpolated on a straight line basis between the two nearest performance levels for pro-rata achievement of the Performance Goals for each 1% above or below Target level performance, rounded down to the nearest whole number; provided that if the actual performance level achieved does not meet the Threshold performance for the Performance Goal, then no shares of Company Stock will be earned.  3-Year Relative TSR will be measured based on the Company’s TSR compared to the S&P Composite 1500- Pharmaceuticals, Biotechnology & Life Sciences Index (the “S&P Index”) over the Performance Period.  The S&P Index companies will be defined on the first day of the Performance Period and any subsequent reconstitution of the S&P Index companies during the Performance Period will not be included.  Notwithstanding the foregoing, in the event of a merger or acquisition or business combination transaction of an S&P Index company by or with an entity that is not in the S&P Index, a “going private” transaction involving an S&P Index company or the liquidation of an S&P Index company, where the S&P Index company is not the surviving entity or is otherwise no longer publicly traded, the company shall no longer be in the S&P Index.  In the event of a bankruptcy of an S&P Index company, such company shall remain in the S&P Index with a cumulative score of negative 100%.  3-Year Relative TSR will be calculated using the 20-trading day average closing price calculated using the average of the closing prices for the 20-trading day period immediately preceding the first and last day of the Performance Period for both the Company and the S&P Index.  For performance above or below Target level, the number of shares earned will increase or decrease for each full 1% above or below Target TSR, up to a maximum of 50% above Target TSR and a minimum of 50% below Target TSR.  

 

 

AUXILIUM PHARMACEUTICALS, INC.

 

2004 EQUITY COMPENSATION PLAN

 

RESTRICTED STOCK UNIT GRANT AGREEMENT

 

This RESTRICTED STOCK UNIT GRANT AGREEMENT (this “Agreement”) dated as of the Date of Grant set forth in the Summary of Grant is delivered by Auxilium Pharmaceuticals, Inc. (the “Company”) to the individual named in the Summary of Grant (the “Grantee”).

 

RECITALS

 

A.                                    The Auxilium Pharmaceuticals, Inc. 2004 Equity Compensation Plan, as amended and restated (the “Plan”), provides for the grant of restricted stock units in accordance with the terms and conditions of the Plan.

 

B.                                    The Compensation Committee of the Board of Directors of the Company (the “Committee”) has decided to make a restricted stock unit grant as an inducement for the Grantee to promote the best interests of the Company and its stockholders.

 

C.                                    The Plan and the Plan prospectus are available on our intranet under “Human Resources” at http://auxlink.auxilium.com/portal/page/portal/Login; provided that paper copies of the Plan and the Plan prospectus are available upon request by contacting the Human Resources Department at jlarmstrong@auxilium.com or 1-484-321-2172.

 

NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:

 

1.                                      Restricted Stock Unit Grant.

 

(a)                                 Subject to the terms, restrictions and conditions set forth in the Summary of Grant, this Agreement and the Plan, the Company hereby grants to the Grantee the right to receive the shares of Company Stock in the amount and on the terms set forth in the Summary of Grant upon achievement of the Performance Goals as set forth in the Summary of Grant and the Grantee continuing to be employed by, or providing service to, the Employer through the Vesting Date. No shares of Company Stock shall be issued to the Grantee on the Date of Grant.

 

(b)                                 The Committee shall, as soon as practicable following the last day of the Performance Period, certify based solely on the criterion set forth herein and in the Summary of Grant (i) the extent, if any, to which, the Performance Goals has been achieved with respect to the Performance Period and (ii) the number of shares of Company Stock, if any, earned upon achievement of the Performance Goals.  Such certification shall be final, conclusive and binding on the Grantee, and on all other persons, to the maximum extent permitted by law. In the event that the Committee makes a final determination that the Performance Goals have not been

 

1

 

achieved based solely on the criterion set forth herein and in the Summary of Grant, the Grantee shall have no further rights to receive shares of Company Stock hereunder.

 

2.                                      Stockholder Rights.  Prior to the issuance, if any, of shares of Company Stock pursuant to the terms of the Summary of Grant, this Agreement and the Plan, the Grantee shall not (a) have any of the rights or privileges of, a stockholder of the Company; (b) have the right to receive any dividends or other distributions; and (c) have any interest in any fund or specific assets of the Company by reason of this Agreement.

 

3.                                      Vesting.

 

(a)                                 The shares of Company Stock subject to this Agreement will become earned based on the actual level of performance achieved with respect to the Performance Goals for the Performance Period on the terms set forth in the Summary of Grant and provided that the Grantee continues to be employed by, or provide service to, the Employer through the Vesting Date set forth in the Summary of Grant.

 

(b)                                 Except as otherwise provided in the Summary of Grant, if the Grantee ceases to be employed by, or provide service to, the Employer for any reason prior to the end of the Performance Period, the Grantee shall forfeit all rights to receive shares of Company Stock hereunder.

 

4.                                      Issuance.

 

(a)                                 Shares of Company Stock equal to the number of shares of Company Stock that the Grantee earns upon achievement of the Performance Goals as set forth in the Summary of Grant shall be issued to the Grantee as set forth in the Summary of Grant, and a certificate representing the Company Stock shall be issued to the Grantee, free of the restrictions under Section 5 of this Agreement.

 

(b)                                 The obligation of the Company to deliver shares of Company Stock to the Grantee on the Payment Date shall be subject to all applicable laws, rules, and regulations and such approvals by governmental agencies as may be deemed appropriate to comply with relevant securities laws and regulations.

 

5.                                      Nonassignability of Company Stock.  During the Performance Period and prior to the Payment Date, the right to receive shares of Company Stock may not be assigned, transferred, pledged or otherwise disposed of by the Grantee, except as permitted under the Plan or by the Committee.  Any attempt to assign, transfer, pledge or otherwise dispose of the right to receive shares of Company Stock contrary to the provisions the Summary of Grant, this Agreement and the Plan, and the levy of any execution, attachment or similar process upon the right to receive the shares, shall be null, void and without effect.

 

6.                                      Change of Control.  Except as otherwise provided in the Summary of Grant, the provisions of the Plan applicable to a Change of Control shall apply to the right to receive the Company Stock issuable upon achievement of the Performance Goals.

 

2

 

7.                                      Grant Subject to Plan Provisions.  This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan.  This grant is subject to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a) rights and obligations with respect to withholding taxes, (b) the registration, qualification or listing of the shares, (c) changes in capitalization of the Company and (d) other requirements of applicable law.  The Committee shall have the authority to interpret and construe this Agreement pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.

 

8.                                      Withholding.  The Employer may require that the Grantee pay to the Employer, or make other arrangements satisfactory to the Company to provide for the payment of, any federal, state, local or other taxes that the Employer is required to withhold with respect to the grant or vesting of this grant, or the Employer may deduct from other wages paid by the Employer the amount of any withholding taxes due with respect to this grant.  Subject to the Committee’s approval, the Grantee may elect to satisfy any tax withholding obligation of the Employer with respect to this grant by having shares withheld up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state, local and other tax liabilities.

 

9.                                      No Employment or Other Rights.  This grant shall not confer upon the Grantee any right to be retained by or in the employ or service of the Employer and shall not interfere in any way with the right of the Employer to terminate the Grantee’s employment or service at any time.  The right of the Employer to terminate at will the Grantee’s employment or service at any time for any reason is specifically reserved.

 

10.                               Company Policies.  Except as otherwise provided in a written agreement by and between the Grantee and the Employer, the Grantee agrees that the Grantee will be subject to any compensation, clawback and recoupment policies that may be applicable to the Grantee as an employee of the Employer, as in effect from time to time and as approved by the Board of Directors or a duly authorized committee thereof, whether or not approved before or after the Date of Grant.  In addition, the Grantee agrees that he/she shall comply with all rules, regulations, policies and procedures of the Company, as in effect from time to time, including the Company’s Code of Conduct and Insider Trading Policy, as amended from time to time, and any rules or policies that may be adopted by the Company from time to time to restrict or prohibit actual or perceived conflicts of interest.

 

11.                               Assignment by Company.  The rights and protections of the Company hereunder shall extend to any successors or assigns of the Company and to the Company’s parents, subsidiaries, and affiliates.  This Agreement may be assigned by the Company without the Grantee’s consent.

 

12.                               Applicable Law.  The validity, construction, interpretation and effect of this instrument shall be governed by and construed in accordance with the laws of the State of Delaware without giving effect to the conflicts of laws provisions thereof.

 

13.                               Notice.  Any notice to the Company provided for in this instrument shall be addressed to the Company in care of the Chief Executive Officer and President, with a copy to its Chief Administrative Officer and General Counsel, at the corporate headquarters of the Company, and

 

3

 

any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of the Employer, or to such other address as the Grantee may designate to the Employer in writing.  Any notice shall be delivered by hand, sent by telecopy or enclosed in a properly sealed envelope addressed as stated above, registered and deposited, postage prepaid, in a post office regularly maintained by the United States Postal Service.

 

14.                               Application of Section 409A of the Internal Revenue Code.  This Agreement, including the right to receive shares of Company Stock upon achievement of the Performance Goals on the Payment Date, is intended to be exempt from the requirements of section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to the short-term deferral exemption thereunder, and this Agreement, including the right to receive shares of Company Stock upon the achievement of the Performance Goals on the Payment Date, shall be interpreted on a basis consistent with such intent.

 

Notwithstanding any provision in this Agreement to the contrary, if the Grantee is a “specified employee” (as defined in section 409A of the Code) and it is necessary to postpone the commencement of any payments otherwise payable under this Agreement to prevent any accelerated or additional tax under section 409A of the Code, then the Company will postpone the payment until five (5) days after the end of the six-month period following the original payment date.  If the Grantee dies during the postponement period prior to the payment of postponed amount, the amounts withheld on account of section 409A of the Code shall be paid to the personal representative of the Grantee’s estate within sixty (60) days after the date of the Grantee’s death.  The determination of who is a specified employee, including the number and identity of persons considered specified employees and the identification date, shall be made by the Committee in accordance with the provisions of sections 416(i) and 409A of the Code.

 

In no event shall the Grantee, directly or indirectly, designate the calendar year of payment.  This Agreement may be amended without the consent of the Grantee in any respect deemed by the Committee to be necessary in order to preserve compliance with section 409A of the Code or other applicable law.

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]